EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive

Haolong Li, Song Liu, Xu Wang, Xinxin Feng, Siyu Wang, Yanli Zhang, Fengchun Zhang, Li Wang, Tengda Xu, Yongzhe Li

Clinical and Molecular Hepatology · 2025

DOI: 10.3350/cmh.2024.0416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Haolong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy …. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Autoantibodies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National High Level Hospital Clinical Research Funding, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds/Aims: Anti-mitochondrial M2 antibody (AMA-M2) is a specific marker for primary biliary cholangitis (PBC) and it could be also present in non-PBC individuals.

Methods

A total of 72,173 Chinese health check-up individuals tested AMA-M2, of which non-PBC AMA-M2 positive individuals were performed follow-up. Baseline data of both clinical characteristics and laboratory examinations were collected in all AMA-M2-positive individuals. Least absolute shrinkage and selection operator (LASSO) regression was performed to investigate the potential variables for developing PBC.

Results

A total of 2,333 individuals were positive with AMA-M2. Eighty-two individuals had a medical history of PBC or fulfilled the diagnostic criteria of PBC at baseline, and 2,076 individuals were non-PBC. After a median follow-up of 6.6 years, 0.6% developed PBC, with an accumulative 5-year incidence rate of 0.5%. LASSO regression showed that levels of alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), immunoglobulin M (IgM), eosinophilia proportion (EOS%), gamma globulin percentage, and hemoglobin (HGB) were potential variables for developing PBC. Multivariate Cox regression is used to construct a predictive model based on 7 selected variables, and time-dependent receiver operating characteristic analysis showed that the area under the curve of the prediction model at 3, 5, and 10 years were, respectively, 1.000, 0.875, and 0.917.

Conclusions

This study offers insights into the onset of PBC among individuals who tested positive for AMA-M2 during routine health check-ups. The prediction model based on ALP, GGT, IgM, EOS%, gamma globulin percentage, HGB, and sex has a certain predictive ability for the occurrence of PBC in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Cirrhosis, BiliaryAutoantibodiesHumansMaleFemaleMiddle Agedgamma-GlutamyltransferaseAdultFollow-Up StudiesROC CurveAlkaline PhosphataseAgedProportional Hazards ModelsImmunoglobulin MBiomarkersHemoglobins

Stichwörter der Autor:innen

Anti-mitochondrial M2 antibodyHealth check-upPrimary biliary cholangitis

Substanzen

Autoantibodiesgamma-GlutamyltransferaseAlkaline PhosphataseImmunoglobulin MBiomarkersHemoglobins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Center for Bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colleg…
  • Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical Coll…
  • Department of Health Management, Peking Union Medical College Hospital, Beijing, China.

Förderung

  • National High Level Hospital Clinical Research Funding
  • National Key Research and Development Program of China

Zitieren

APA

Li, H., Liu, S., Wang, X., Feng, X., Wang, S., Zhang, Y., Zhang, F., Wang, L., Xu, T., & Li, Y. (2025). Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0416

Vancouver

Li H, Liu S, Wang X, Feng X, Wang S, Zhang Y, et al. Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2024.0416

BibTeX
@article{Li2025,
  author = {Li, Haolong and Liu, Song and Wang, Xu and Feng, Xinxin and Wang, Siyu and Zhang, Yanli and Zhang, Fengchun and Wang, Li and Xu, Tengda and Li, Yongzhe},
  title = {Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive},
  journal = {Clinical and Molecular Hepatology},
  year = {2025},
  doi = {10.3350/cmh.2024.0416}
}
Kostenlos starten →